Advertisement

Advertisement

MIRA Stock Latest News

MIRA Pharmaceuticals Highlights Encouraging Safety Data for Mira-55

Company AnnouncementsMIRA Pharmaceuticals Highlights Encouraging Safety Data for Mira-55

Mira reports Mira-55 shows no THC-, Rimonabant-associated CNS side effects

PremiumThe Fly

Mira reports Mira-55 shows no THC-, Rimonabant-associated CNS side effects

1M ago

Mira Pharmaceuticals completes Phase 1 dosing of Ketamir-2

PremiumThe Fly

Mira Pharmaceuticals completes Phase 1 dosing of Ketamir-2

2M ago

MIRA Completes Phase 1 Trial of Ketamir-2 Therapy

PremiumCompany Announcements

MIRA Completes Phase 1 Trial of Ketamir-2 Therapy

2M ago

Psychedelic: Analyst initiates Definium, Helus with Buy ratings

PremiumThe Fly

Psychedelic: Analyst initiates Definium, Helus with Buy ratings

3M ago

Mira Pharmaceuticals initiates final cohort of Ketamir-2 Phase 1 study

PremiumThe FlyMira Pharmaceuticals initiates final cohort of Ketamir-2 Phase 1 study

3M ago

MIRA Pharmaceuticals Advances Ketamir-2 Phase 1 to Final Cohort

Company Announcements

MIRA Pharmaceuticals Advances Ketamir-2 Phase 1 to Final Cohort

3M ago

Mira Pharmaceuticals initiated with a Buy at Rodman & Renshaw

The Fly

Mira Pharmaceuticals initiated with a Buy at Rodman & Renshaw

4M ago

MIRA Pharmaceuticals Expands Stock Offering by $15M

PremiumCompany Announcements

MIRA Pharmaceuticals Expands Stock Offering by $15M

5M ago

Psychedelic: Compass Pathways, NeuroKaire enter R&D collaboration

PremiumThe Fly

Psychedelic: Compass Pathways, NeuroKaire enter R&D collaboration

6M ago

Mira Pharmaceuticals initiates MAD Phase 1 study of oral ketamir-2

PremiumThe Fly

Mira Pharmaceuticals initiates MAD Phase 1 study of oral ketamir-2

6M ago

MIRA Pharmaceuticals Advances Ketamir-2 Clinical Trials

PremiumCompany Announcements

MIRA Pharmaceuticals Advances Ketamir-2 Clinical Trials

6M ago

MIRA Pharmaceuticals Sells Shares at 66% Premium

PremiumCompany AnnouncementsMIRA Pharmaceuticals Sells Shares at 66% Premium

7M ago

Mira Pharmaceuticals announces preclinical data on oral Mira-55

The Fly

Mira Pharmaceuticals announces preclinical data on oral Mira-55

7M ago

MIRA Pharmaceuticals’ Mira-55 Outperforms Morphine in Study

Company Announcements

MIRA Pharmaceuticals’ Mira-55 Outperforms Morphine in Study

7M ago

Mira Pharmaceuticals closes acquisition of SKNY Pharmaceuticals

PremiumThe Fly

Mira Pharmaceuticals closes acquisition of SKNY Pharmaceuticals

7M ago

MIRA Pharmaceuticals Completes SKNY Acquisition

PremiumCompany Announcements

MIRA Pharmaceuticals Completes SKNY Acquisition

7M ago

Mira Pharmaceuticals announces topline results from Phase 1 SAD study

PremiumThe Fly

Mira Pharmaceuticals announces topline results from Phase 1 SAD study

8M ago

MIRA Pharmaceuticals Reports Positive Phase 1 Study Results

PremiumCompany Announcements

MIRA Pharmaceuticals Reports Positive Phase 1 Study Results

8M ago

Mira Pharmaceuticals reports Ketamir-2 data in PTSD

PremiumThe FlyMira Pharmaceuticals reports Ketamir-2 data in PTSD

8M ago

MIRA Pharmaceuticals Reports Positive Ketamir-2 Study Results

Company Announcements

MIRA Pharmaceuticals Reports Positive Ketamir-2 Study Results

8M ago

Mira Pharmaceuticals shareholders approve acquisition of SKNY Pharmaceuticals

The Fly

Mira Pharmaceuticals shareholders approve acquisition of SKNY Pharmaceuticals

8M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >